Fig. 2From: Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy systemLocal control rates of all tumors (a), T1a + T1b tumors and T2a + T2b tumors (b), respectivelyBack to article page